首页> 外文期刊>Diabetes research and clinical practice >Impaired antioxidant action of high density lipoprotein in patients with type 1 diabetes with normoalbuminuria and microalbuminuria
【24h】

Impaired antioxidant action of high density lipoprotein in patients with type 1 diabetes with normoalbuminuria and microalbuminuria

机译:高密度脂蛋白在1型糖尿病患者中有受损的抗氧化作用型糖尿病患者和微蛋氨酸

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: Patients with type 1 diabetes, in the absence of chronic complications, have serum concentrations of high density lipoprotein cholesterol (HDL-C) similar to the general population. However, their HDL particles may be dysfunctional. We aimed to evaluate the antioxidant effect of HDL2 and HDL3 obtained from Caucasian males with type 1 diabetes with normoalbuminuria and microalbuminuria. Methods: Twenty Caucasian men with type 1 diabetes (10 with normoalbuminuria and 10 with microalbuminuria) and 10 healthy Caucasian men participated in the study. Lipoproteins were obtained by density gradient ultracentrifugation. The antioxidant effect of HDL was assessed by measuring lipid hydroperoxide (LOOH) concentration after 3h of pooled LDL oxidation catalyzed by 5μM CuSO4 in the absence or presence of HDL2 or HDL3. Results: The control, normoalbuminuria, and microalbuminuria groups had similar HDL-C concentration and estimated glomerular filtration rate. Glycemic control was similar between diabetes groups (HbA1c 8.1 ± 0.9% and 8.3 ± 0.7%, P= 0.70), but estimated glucose disposal rate was lower in patients with microalbuminuria (8.0 ± 0.6 and 4.5 ± 1.1. mg/kg/min, P 0.01). The relative antioxidant effect of HDL2 from control, normoalbuminuria, and microalbuminuria groups were 92.8 ± 2.4%, 85.4 ± 1.7%, and 74.2 ± 4.6%, respectively (P 0.01), and the HDL3 effect were 95.0 ± 2.2%, 86.4 ± 4.4%, and 75.3 ± 4.2%, respectively (P 0.01). Conclusion: Both HDL2 and HDL3 inhibited LOOH formation in copper-catalyzed oxidation of LDL in vitro. Overall, this antioxidant effect was lower in Caucasian men with type 1 diabetes, and was further compounded in those with microalbuminuria.
机译:目的:1型糖尿病患者,在没有慢性并发症的情况下,具有类似于一般人群的高密度脂蛋白胆固醇(HDL-C)的血清浓度。然而,它们的HDL颗粒可能具有功能障碍。我们旨在评估HDL2和HDL3从白种人男性中获得的抗氧化效果与型1型糖尿病患者与Normoalbuminuria和微蛋白尿。方法:二十个白种人男性患有1型糖尿病(10种含有Namoalbuminuria和10种带微巴蛋氨酸)和10名健康高加索人参加了这项研究。通过密度梯度超速离心获得脂蛋白。通过在没有或存在HDL2或HDL3的情况下在催化或存在下催化5μmCuSO4的合并LDL氧化后测量脂质氢过氧化物(LOOH)浓度来评估HDL的抗氧化效应。结果:对照,正常白蛋白尿和微蛋白尿基因组具有类似的HDL-C浓度和估计的肾小球过滤速率。糖尿病基团(HBA1C 8.1±0.9%和8.3±0.7%,P = 0.70)之间相似,但微量白蛋白尿的患者(8.0±0.6和4.5±1.1,估计葡萄糖处理率较低。Mg / kg / min, P& 0.01)。 HDL2从对照,正常蛋白尿和微蛋白尿基团的相对抗氧化作用分别为92.8±2.4%,85.4±1.7%和74.2±4.6%(P <0.01),HDL3效应为95.0±2.2%,86.4± 4.4%,分别为75.3±4.2%(P <0.01)。结论:HDL2和HDL3均在体外铜催化氧化铜催化氧化中的LOOH形成。总的来说,这种抗氧化效果在1型糖尿病的白种人男性中较低,并进一步混合在具有微白蛋白尿的那些中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号